Highland Therapeutics, a Toronto-based company with delayed-release technology for ADHD treatment, said data from the first of two Phase III trials for its…

Australia's Adherium Group announced clearance to sell its SmartTurbo and SmartTouch "smart inhaler" devices in Canada. They improve…

Several drug delivery devices are on a draft list of med tech that will be subject to a final guidance calling for the application of human factors and…

Researchers at the University of California in Santa Barbara have formulated drugs as liquid salts to enable delivery through the skin without the toxicity…

Computational drug delivery specialist Qrono has just been awarded a $612,000 FDA contract to design and deploy physiologically based pharmacokinetic models of…

Impax Pharma announced that the European Commission has approved its modified-release combination of carbidopa and levodopa to treat Parkinson's disease,…

Adapt Pharma's Narcan nasal spray became the first noninjectable treatment for opioid overdose emergencies thanks to its FDA approval on Nov. 19.

GlaxoSmithKline secured FDA approval for Nucala, an injectable treatment for asthma, a therapeutic dominated by inhaled drugs. Still, the alternative form of…

Regulatory